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A B S T R A C T
In this work, we are going to study the interactions of cabergoline (CBG) with human serum albumin (HSA) by
mathematical modeling of voltammetric and spectroscopic data. To achieve this goal, voltammetric and spec-
troscopic data will be augmented into a data matrix which will be resolved by multivariate curve resolution-
alternating least squares (MCR-ALS) as a powerful chemometric tool. Then, the quality of the data fitting by
MCR-ALS will be examined by MCR-BANDS to ensure about the absence of the rotational ambiguities in the
results. Molecular docking will also be used to model the interactions of CBG with HSA for verifying the results
obtained from experimental methods. Hard-modeling of the experimental data will be performed by EQUISPEC
to compute the binding constant of the complex formed from the interactions of CBG with HSA for verifying the
binding constant obtained by direct analysis of the experimental data. Finally, two chrono-amperometric
measurements based on CBG-HSA interactions will be performed to develop a novel electroanalytical method for
determination of electro-inactive HSA.
1. Introduction
Cabergoline (CBG, Fig. 1A) an ergot derivative, is a long-acting
dopamine agonist and prolactin inhibitor. It is used to treat hyperpro-
lactinemic disorders and Parkinsonian Syndrome [1]. It acts by direct
stimulation of the D2-dopamine receptors on pituitary lactotrophs, thus
inhibiting Prolactin secretion.
Human serum albumin (HSA, Fig. 1B) as the most abundant protein
in blood plasma can act as a shuttle for small molecules [2–8]. There-
fore, free concentration and distribution of the small molecules are
depended on their interactions with HSA. According to the information
mentioned above, it is important to investigate the interactions of drugs
with HSA. It should be noted that unusual concentrations of HSA in
blood serum is an important factor for detection of some diseases,
therefore, determination of HSA in blood serum is important. Common
techniques for determination of HSA are included capillary electro-
phoresis, immunoassays, LC-MS/MS and surface enhanced Raman
scattering which are expensive and time-consuming. Therefore, devel-
oping new analytical techniques for determination of HSA which are
simple and mow-cost are highly demanded.
Common methods for investigation of drug-HSA interactions are
including UV–Vis spectrophotometry [9], FT-IR [10], electrochemistry
[11], capillary electrophoresis [12], HPLC [13], and NMR [14] and
some of them have been assisted by chemometric methods by the other
researchers [15,16]. HSA-drug interaction is a complex system and its
monitoring is complicated because free drug, free HSA and their com-
plex product must be simultaneously monitored. Therefore, investiga-
tion of HSA-drug interaction must be assisted by chemometric methods.
Multivariate curve resolution-alternating least squares (MCR-ALS) is a
powerful chemometric tool which is able to the simultaneous analysis
of the data with different origins to obtain valuable information about
the studied system which cannot be obtained by the use of conventional
methods. Therefore, we will use MCR-ALS for further analysis of CBG-
HSA interactions.
The steps of our study will be: 1) investigation of interactions of
CBG with HSA by direct analysis of voltammetric and spectroscopic
data, 2) using voltammetric and spectroscopic data to build an aug-
mented data matrix as the input of MCR-ALS to obtain new information
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about CBG-HSA interactions, 3) modeling of CBG-HSA interactions by
molecular modeling methods and 4) developing a novel electro-
analytical methodology based on CBG-HSA interactions for determi-
nation of HSA.
2. Experimental and theoretical details
2.1. Experimental details
2.1.1. Chemicals and solutions
HSA, CBG, warfarin (Wr), ibuprofen (Ip), acetic acid, ethanol, di-
methylformamide (DMF), sodium phosphate monobasic (NaH2PO4),
sodium phosphate dibasic (Na2HPO4), 1-ethyl-3-methylimidazolium bis
(trifluoromethylsulfonyl)Imide (IL), dimethyl sulfoxide (DMSO), so-
dium hydroxide, phosphoric acid (H3PO4), and hydrochloric acid were
purchased from Sigma. Ionic Liquid Technologies supported us for
preparing multiwalled carbon nanotubes (MWCNTs). Other chemicals
were prepared from legal sources. A phosphate buffer solution (PBS)
with a concentration of 0.05M, pH at 7.4 was prepared and used as the
medium of the interactions. Stock solutions of CBG (0.1M) and HSA
(0.01M) were prepared in PBS (0.05M, pH at 7.4) and kept in a re-
frigerator. Stock solutions of Wr (0.1M) and Ip (0.1M) were prepared
in DMSO. 20mg MWCNTs was dissolved in 1mL DMF containing 30 μL
IL and ultrasonicated for 30min to obtain a homogeneous gel-like
MWCNTs-IL solution.
Three human serum samples were prepared from a medical diag-
nostic laboratory and centrifuged at 4500 rpm for 20min and then,
5mL of each sample was diluted with 45mL PBS (0.05M, pH 7.4). For
HSA determination, each sample was amperometrically analysed.
2.1.2. Instruments and softwares
All the electrochemical data were recorded by an Autolab
PGSTAT302N-high performance controlled by the NOVA 2.1.2 soft-
ware. Electrochemical measurements were performed by a bare or
modified glassy carbon electrode (GCE), a Pt wire and an Ag/AgCl
electrode acted as working, counter and reference electrode, respec-
tively. A KYKY-EM 3200 scanning electron microscope was used to
capture the SEM image. A Cary Eclipse fluorescence spectrophotometer
equipped with a water bath and a 1.0 cm quartz cell was used to record
the spectrofluorimetric data and a Shimadzu spectrophotometer
equipped with a 1.0 cm quartz cell was used to record the spectro-
photometric data. An ELMEIRON pH-meter (CP-411) was used to adjust
the pH of the solutions. The molecular structure of the CBG was con-
structed by Hyperchem package (Version 8.0) and the PDB file of HSA
(PDB Id: 1AO6) was downloaded from the internet. The Molegro virtual
docker (MVD) software was used to dock CBG with HSA. LIGPLOT [17],
was used to plot the interactions of CBG and HSA. The m-files of MCR-
ALS and MCR-BANDS were downloaded from the internet [18].
2.1.3. Fabrication of the modified electrodes
To fabricate the HSA/GCE, 12 μL HSA (10−5M) was drop-casted
onto the surface of the cleaned GCE and dried at room temperature. To
fabricate MWCNTs-IL/GCE, 10 μL MWCNTs-IL was drop-casted onto the
surface of the cleaned GCE and dried at room temperature. The SEM
images captured from the surface of HSA/GCE and MWCNTs-IL/GCE
are shown in Fig. 2.
2.1.4. Procedures
Spectroscopic experiments were performed in a quartz cell. For each
experiment, HSA or CBG was added step-by-step to a quartz cell con-
taining 2mL of HSA or CBG while the added volume was less than
0.2 mL. Spectroscopic titrations were performed by manual shanking
where each solution was allowed to be equilibrated for 15 s.
In voltammetric experiments, 5 mL of HSA or CBG with a known
concentration was added to a cell and titrated by different volumes of
HSA or CBG while the total added HSA or CBG was less than 0.5mL.
Each solution was shaken manually left to be equilibrated for 1.0 min
and then, its voltammogram was recorded.
2.1.5. Experiments required to construct an augmented data matrix for the
analysis by MCR-ALS
All the voltammetric and spectroscopic experiments have been
coded in Table S1.
2.2. Theoretical details
2.2.1. Requirements for applying MCR-ALS to the augmented data matrix
Some works have been reported on application of MCR-ALS to the
Fig. 1. (A) Molecular structure of CBG and (B) secondary structure of HSA.
A.R. Jalalvand, et al. Sensing and Bio-Sensing Research 25 (2019) 100297
2
electroanalytical data [19–22] and in this section, a summarized de-
scription will be given. MCR can decompose a voltammetric or spec-
troscopic data matrix (D (M×N), M objects and N variables e.g. wa-
velength or potential) according to the following equation:
= +D CS ET (1)
where C (M×P), ST (P×N) and E (M×N) contains the concentration
profiles of the P species, pure signals and residuals, respectively. ALS is
an iterative approach which can be used to optimize the outputs of the
MCR. MCR-ALS can also be applied to the analysis of an augmented
data matrix having more than one instrumental data. In this work, CBG-
HSA interactions will be studied by differential pulse voltammetry
(DPV), linear sweep voltammetry (LSV), cyclic voltammetry (CV),
UVVis spectrophotometry and fluorescence spectroscopy (F), and the
individual instrumental data matrices were augmented as shown below:
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DDPV, DLSV, DCV, DUVVis and DF contain the data recorded by DPV,
LSV, CV, UVVis and F as instrumental techniques. CCBG and CHSA con-
tain the concentration profiles.
Evolving Factor Analysis (EFA) is able to provide an initial
estimation of changing concentration of the species during the experi-
ment [23–26], and during ALS optimization some constraints are used
to facilitate the finding of representative contributions and to obtain
chemically meaningful results [26]. The lack of fit (lof) is a criterion to
examine the goodness of fit of the model which can be calculated ac-
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where dij and eij refer to the elements of the raw data and their corre-
sponding residuals, respectively.
The solutions which are used by MCR are not unique and may have
some rotational and intensity ambiguities and matrix augmentation can
tackle this problem. Furthermore, this method can be useful to over-
come small signal shifts observed in the data as well. Therefore, an
augmented data matrix was built and submitted for the resolution by
MCR-ALS. However, because of combining different types of instru-
mental data, following considerations must not be neglected:
1. Because of the more intensity of the voltammetric data than spec-
troscopic data, all the submatrices must be normalized by dividing
them by their maximum values.
2. Here, the concept of component is more complicated because of
having different types of instrumental data. From spectroscopic
Fig. 2. The SEM image of the surface of (A) HSA/GCE and (B) MWCNTs-IL/GCE.
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point of view, a component is a pure chemical species in solution
[28,29], but for electrochemists a component is more complicated
because from electrochemical point of view, a component not only
associated to a single electrochemical process, but also is associated
with the other phenomena such as adsorption or capacitive currents
[30,31].
3. For combining voltammetric and spectroscopic matrices to build an
augmented data matrix, all the matrices must have a same number
of rows and columns and a same distribution of the species during
the experiments. Achieving this goal needs a same total concentra-
tion in all titrations for both of CBG and HSA. Achieve to this con-
dition is impossible, because for voltammetric experiments higher
concentrations are needed than spectroscopic ones. To tackle this
problem, all the voltammetric and spectroscopic experiments were
performed at different total concentrations but with the same values
of ratio.
3. Results and discussion
3.1. Voltammetric studies of CBG-HSA interactions
3.1.1. CV studies
CV as a powerful electroanalytical technique has been frequently
used to investigate protein-small molecule interactions [32]. Therefore,
in this section, we have use it for investigation of CBG-HSA interactions.
To achieve this goal, to a solution containing a constant concentration
of CBG (1.0×10−4M) HSA was added in the range of 0–1.0×10−4M
and the results are shown in Fig. 3A. The CV response of CBG can be
seen as the first CV of Fig. 3A, and by adding HSA to CBG, the peak
intensity and peak potential were decreased and increased, respec-
tively, which confirmed the interactions of CBG with HSA [33]. The
mentioned phenomena also confirmed interactions of CBG with hy-
drophobic region of the HSA cavity. Ep and Ep/2 values of the CV re-
sponse of the CBG at the GCE surface were 170 and 140mV, respec-
tively. According to |Ep – Ep/2|= 47.7/αn [34] which is related to an
irreversible oxidation, where n is the electron transfer number and
α=0.5 [35], n was calculated to be 3.18 i.e. ∼ 3.
Immobilization of a biological macromolecule such as HSA at the
GCE surface can give us some information about the type of interactions
of a small molecule with HSA [36,37]. Therefore, the CV response of
CBG at bare GCE (curve a) and HSA/GCE (curve b) were recorded and
can be seen in Fig. 3B. As can be seen, the CV response of the CBG at the
surface of HSA/GCE was appeared in more positive potentials which
confirmed that the CBG-HSA interactions were occurred by hydro-
phobic forces [36].
The binding constant of CBG-HSA complex was computed with the
help of CV by recording the CVs of different concentrations of CBG at
the surface of HSA/GCE (not shown). The intensity of the CVs was in-
creased with increasing concentration of CBG (CCBG) and reached to
saturation values. According to Eq. (4) [38], where I, Imax, and Kb are
the peak current, maximum peak current and the binding constant of
CBG at the surface of HSA/GCE, respectively, the Kb value was
Fig. 3. (A) The CV responses of 1.0× 10−4M CBG in the presence of increasing concentration of HSA ranging in 0–1.0× 10−4M, (B) the CV responses of
5.0× 10−4M CBG at the surface of bare GCE (curve a) and HSA/GCE (curve b), (C) the LSV responses of 1.0× 10−4M CBG in the presence of increasing
concentration of HSA ranging in 0–1.0× 10−4M and (D) the DPV responses of 1.0× 10−5M CBG in the presence of increasing concentration of HSA ranging in
0–1.0×10−5M.
A.R. Jalalvand, et al. Sensing and Bio-Sensing Research 25 (2019) 100297
4
calculated to be 4.11× 105mol−1 L by the regression of CCBG/I on
CCBG.
= +C I K I I/ (1/ ) (C / )bCBG max CBG max (4)
3.1.2. LSV and DPV studies
The LSVs and DPVs of CBG at the surface of GCE upon increasing
HSA concentration were recorded in the PBS (0.05M, pH 7.4) and are
presented in Fig. 3C and D, respectively. As can be seen, by the addition
of HSA the CVs of CBG were decreased and shifted to more positive
potentials which were related to the CBG-HSA interactions. During in-
teraction of CBG with HSA, the equilibrium concentration of CBG is
decreased due to locating of the CBG in the HSA structure. Competitive
adsorption at the GCE surface is another phenomenon which may be
occurred. When a low concentration of a biological macromolecule
such as HSA is interacted with a small molecule, only a low area of the
electrode surface (10%) is covered which confirms a low competitive
adsorption of the small molecules at the surface of the electrode
[39,40]. Therefore, the changes observed in the CV response of CBG in
the presence of increasing concentration of HSA were related to inter-
action of CBG with HSA and complex formation. But multivariate
analysis of the data in next sections will help us to have a better
judgment about CBG-HSA interactions.
3.2. Spectroscopic studies of CBG-HSA interactions
3.2.1. Spectrofluorimetry
The fluorescence emission spectra of 2.0× 10−7M HSA
(λex= 280 nm) upon increasing concentration of CBG,
0.0–1.0×10−6M, were recorded at three different temperatures (i.e.,
298.15, 304.15 and 310.15 K) and one of them (298.15 K) is shown in
Fig. 4A. As can be seen, the intensity of the emission of HSA was de-
creased with increasing CBG concentration. The intrinsic fluorescence
HSA is related to its Trp-214 and by the interaction of a small molecule
with HSA, its fluorescence intensity is decreased [41]. Fluorescence
quenching can be occurred by different molecular interactions such as
energy transfer, molecular rearrangements, excited state reactions,
ground state complex formation, and collisional quenching. Usually,
quenching is occurred by dynamic collision and static quenching
(complex formation) and to declare the mechanism of quenching, Stern-
Volmer equation is used [42]:
= +F F K Q/ 1 [ ]0 SV (5)
where F0 and F are the steady-state fluorescence intensities in the ab-
sence and presence of CBG as the quencher, respectively, and KSV is the
Stern-Volmer quenching constant. According to Eq. (5), the results of
the regression of F0/F on concentrations of CBG are presented in Table
S2. As can be seen, the KSV values are decreasing with increasing
temperature suggesting a static quenching (complex formation) for
quenching of HSA by CBG.
3.2.2. Site selectivity of binding of CBG to HSA
There are two sites in HSA including site I (hydrophobic sub-domain
IIA) [43] and Sudlow's sites II (sub-domain IIIA) [44] which enable
small molecules for binding with HSA. For identifying the location of
binding of CBG with HSA, we performed two competitive experiments
with two site markers including Wr (marker of site I) and Ip (marker of
site II). To perform these competitive experiments, to a solution con-
taining CBG and HSA where CBG concentration (2.0×10−7M) was
four times higher than that of HSA (5.0×10−8M) Wr or Ip was added
in the range of 0.0–2.0×10−7M. Subsequently, (F1/F2)× 100 (F1 and
F2 refer to the fluorescence intensity in the absence and presence of Wr
or Ip as site marker, respectively) was plotted against [Site Marker]/
[HSA] and the results are shown in Fig. 4B. The variations observed by
the addition of site marker to the mixture of CBG and helped us to
distinguish the binding location of CBG on HSA. The results showed
that (F1/F2)× 100 was decreased by the addition of Wr to the HSA-CBG
solution (Fig. 4B, curve a) which confirmed that the binding of CBG
with HSA was affected by the addition of Wr. By doing the same pro-
cedure but in the presence of Ip, the (F1/F2)× 100 was not affected
(Fig. 4B, curve b) which confirmed that the binding of CBG with HSA
was not affected by Ip. The results obtained from the experiments
mentioned above confirmed that Wr is competed with CBG while Ip
does not. Therefore, the binding site of CBG was located in sub-domain
IIA of HSA.
3.2.3. Spectrophotometry
Interaction of CBG with HSA was also investigated spectro-
photometrically by the titration of 5.0× 10−5M HSA with increasing
concentration of CBG in the range of 0.0–2.5×10−4M and the spectra
are shown in Fig. 4C. As can be seen, the position and intensity of the
absorbance peak of HSA at 280 nm were affected by the addition of CBG
which confirm the interactions of CBG with HSA.
3.2.4. Energy transfer from HSA to CBG and measurement of the binding
distance
Fluorescence energy transfer (FRET) as a general spectroscopic
method is usually used to determine the molecular distance in biolo-
gical systems [45]. The efficiency (E, Eq. (6)) of FRET is affected by
some factors such as the inverse sixth power of the distance between
donor and acceptor (r) that should be be within 2–8 nm which is also
called Forster distance [46], Forster radius (R0, Eq. (7)), overlapping of
the emission of the donor with the absorption of the acceptor and or-
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n and k2 are refractive index of the medium and spatial factor of
orientation, respectively. Φ and J fluorescence are quantum yield of the
donor and the overlap integral of the fluorescence emission spectrum
for the donor and the absorption spectrum of the acceptor, respectively.









where F(λ) is the fluorescence intensity of the donor and ε is molar
absorption coefficient of the acceptor. Values of k2, n and Φ are 2/3,
1.336 and 0.118, respectively, which can be found elsewhere [47].
According to the values mentioned above, J, R0, E and r were calculated
to be 5.14× 10−14 cm3M−1, 3.22 nm, 0.01 and 3.21 nm, respectively.
As can be seen, r is fallen in Forster distance which confirms that the
energy transfer can be ocurred from HSA to CBG [48].
3.3. Combination of voltammetric and spectroscopic data
In this section of our study, we have built an augmented data matrix
by the combination of voltammetric and spectroscopic data which was
used as the input of MCR-ALS. In next section, we will justify the out-
puts of MCR-ALS.
3.3.1. Justification of the MCR-ALS results
In order to obtain more information about interactions of CBG with
HSA, the augmented data matrix was analysed by MCR-ALS. The out-
puts of MCR-ALS can help us to detect any HSA-CBGm complex and to
obtain relative concentrations of the various species. To build the
augmented data matrix, individual data matrices including DPV
(DDPVCBG, Fig. 3D, DDPVHSA, Fig. 4D), LSV (DLSVCBG, Fig. 3C, DLSVHSA,
Fig. 5A), CV (DCVCBG, Fig. 3A, DCVHSA, Fig. 5B), UVVis (DUVVisCBG,
Fig. 5C, DUVVisHSA, Fig. 4C) and F (DFHSA, Fig. 4A, DFCBG, Fig. 5D) were
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column- and row-wise augmented.
The first attempt was included using singular value decomposition
(SVD) for determination of the number of species and after applying it
to the augmented data matrix, three main components were detected
which may be related to free CBG, free HSA and one HSA-CBGm com-
plex species. The second attempt was including application of the EFA
to obtain an initial estimate of the concentration profiles of the involved
species. The EFA can work with a full rank data matrix and its appli-
cation to a rank-deficient data matrix cannot give us useful information.
This problem can be tackled by matrix augmentation [49]. In MCR-ALS
because of using constraints more reliable results could be obtained. In
our work, because of the presence of the CV data which contain ne-
gative values in their reverse direction, the non-negativity constraint
was only applied to the concentration profiles and application of the
closure constraint to the matrices obtained at different concentration
levels was not possible.
With the conditions mentioned above, the iterative ALS was used to
optimize the results of MCR and the lof was used to evaluate the
goodness of the fitting procedure. Here, a value of 4.88% was found as
the lowest value for lof which confirmed an acceptable fitting procedure
by MCR-ALS. The results of MCR-ALS are shown in Figs. 6 and 7.
Fig. 6A and B are related to the concentration profiles of the species.
According to Fig. 6A, by the addition of HSA to CBG, CBG concentration
is decreased and a new complex is forming. By casting a look on the
variation of the concentration of the complex specie, it can be found
that its concentration is sharply increased at [HSA]/[CBG]~0.5 which
confirms forming a HSA-CBG2 complex specie. Fig. 6B shows that the at
[CBG]/[HSA]~2 concentration of the complex is equilibrated and
concentrations of HSA and CBG are vigorously decreased and increased,
respectively. The results obtained from the analysis of the details of
Fig. 6B confirms complex formation is mainly occurred at [CBG]/[HSA]
~2 which also confirms that the complex specie is HSA-CBG2. The pure
voltammetric and spectral profiles obtained by MCR-ALS are shown in
Fig. 7A-E which can help us to obtain new information about the nature
of the species. The results show that HSA is electro-inactive with its
original structure while the complex specie is electroactive. By locating
the CBG within the HSA structure, the protein will be unfolded which
cause tryptophan and tyrosine residues to be accessible for oxidation at
the electrode surface. Therefore, the complex will be electroactive. A
plot with coincided experimental and theoretical points (Fig. 7F) was
obtained for the fitting procedure which confirms the existence of a
high-quality fitting procedure.
3.3.2. Verification of the existence of ambiguities in MCR-ALS results by
MCR-BANDS
As mentioned in previous sections, application of constraints can
help us to obtain reliable and meaningful results for MCR-ALS which is
an important advantage for MCR-ALS [50]. However, sometimes, a
band of feasible solutions are applied instead of a unique solution which
may cause the existence of some ambiguities in the results [51].
Fig. 4. (A) Spectrofluorimetric data recorded for 2.0×10−7M HSA (λex= 280 nm) in the presence of increasing concentration of CBG in the range of
0–1.0×10−6M, (B) effects of Wr (curve a) and Ip (curve b) on the fluorescence emission of HSA-CBG, (C) UVVis absorption spectra of 5.0× 10−5M HSA in the
presence of increasing concentration of CBG in the range of 0–2.5×10−4M and (D) the DPV responses of 1.0×10−5M HSA in the presence of increasing
concentration of CBG in the range of 0–5.0×10−5M.
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Therefore, verification of the results of MCR-ALS to identify the pre-
sence of ambiguities is necessary and MCR-BANDS has been developed
as an efficient chemometric tool to compute the maximum and
minimum of the relative contribution of the components for estimating
the feasible solutions which can help us to estimate the extent of ro-
tational ambiguity [50,52,53].
Here, the MCR-BANDS with the same constraints used for MCR-ALS
was applied to results of MCR-ALS and the maximum relative con-
tribution function (fmax) and minimum relative contribution function
(fmin) for each contributing species were calculated to be HSA
(fmax= 0.545 and fmin= 0.545), CBG (fmax= 0.398 and fmin= 0.398)
and HSA-CBG2 (fmax= 0.511 and fmin= 0.511). Fortunately, for all the
species there was no difference between the fmax and fmin which con-
firmed that there wasn't any rotational ambiguity [50].
3.4. Hard-modeling of experimental data
For decomposition of the data matrix D according to Eq. (1) by a
Fig. 5. (A) The LSV responses of 1.0×10−4M HSA in the presence of increasing concentration of CBG in the range of 0–5.0× 10−4M, (B) the CV responses of
1.0× 10−4M HSA in the presence of increasing concentration of CBG in the range of 0–5.0×10−4M, (C) UVVis absorption spectra of 1.0× 10−4M CBG in the
presence of increasing concentration of CBG in the range of 0–1.0× 10−4M CBG and (D) fluorescence emission spectra of 1.0×10−7M CBG in the presence of
increasing concentration of HSA in the range 0–1.0×10−7M.
Fig. 6. (A) and (B) concentration profiles of the species involved extracted as the outputs of MCR-ALS after analyzing the augmented data matrix.
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hard-modeling algorithm, a model must be defined which contains
stoichiometry of the species involved and an estimation of the binding
constant. The defined model is used as an input for the hard-modeling
algorithm to obtain an estimation for the concentration profiles (C) and
then, least squares fitting is applied to resolve the pure spectra (ST) by
the best matching of C and D. The differences between the input data
(D) and the reproduced data matrix by the algorithm are collected into
a residual matrix (E). The hard-modeling algorithm repeats the opti-
mization process until a suitable level of residuals is obtained. For ob-
taining more information about details of the hard-modeling approach,
the reader is referred to read Ref. [54].
In the present work, EQUISPEC as a hard-modeling algorithm was
used to calculate the binding constants and also was used as a criterion
for verifying the results of Section 3.1.1. The results are presented in
Table 1. As can be seen, there is a good agreement between the results
of EQUISPEC and those of Section 3.1.1.
3.5. Molecular docking
In this section, the MVD software was used to build a computer
generated CBG-HSA interaction and the results are shown in Fig. 8A-C.
After docking of CBG to HSA, the binding sites were detected as Trp
Fig. 7. (A)-(E) extracted signals of different species involved in DPV, LSV, CV, F and UVVis experiments, respectively, and (F) plotting experimental (points) and
calculated data (line) as a criterion for evaluation of the goodness of the fitting procedure.
Table 1
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214, Val 343, Arg 218, Arg 222, Asp 451, Lys 195, Val 293, Glu 292,
Glu 294, Ala 449, Cys 448, Tyr 452, Val 433, Cys 437, His 440 and Lys
436. The ΔG for binding of CBG to HSA was calculated to be
−32.15 kJmol−1. As can be seen, CBG has been bound to sub-domain
IIA of HSA which confirmed the results of experimental sections. The
LIGPLOT program was used to detect the hydrogen binding hydro-
phobic interactions between CBG and HSA and the results are shown in
Fig. 8D. By the analysis of the LIGPLOT results, there are two hydrogen
bonds between CBG and Lys 195 and CBG and Arg 218, and hydro-
phobic interactions were observed between CBG and Cys 437, Lys 436,
Fig. 8. Results of docking of CBG to HSA presented by: (A) secondary structure view, (B) pose organizer view and (C) hydrophobicity view. (D) CBG-HSA interactions
presented by LigPlot program.
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Tyr 452, His 440, Cys 448, Asp 451, Val 293, Trp 214, Val 343 and Arg
222 from HSA.
3.6. Analytical characterizations
In this section, we are going to introduce a novel electroanalytical
methodology for determination of HSA based on CBG-HSA interactions.
Due to much higher sensitivity of amperometric methods than vol-
tammetric techniques, electrochemical sensing of HSA was performed
by amperometric methods. Another action which was performed for
increasing the sensitivity of the developed electroanalytical metho-
dology was included modification of the bare GCE which has been
suggested by the previous works [55–59]. Here, the bare GCE was
modified with MWCNTs-IL.
3.6.1. Amperometric measurements
To develop an electroanalytical methodology for determination of
electro-inactive HSA, two different amperometric experiments in the
presence and absence of HSA were performed in a gently stirred
(1000 rpm) PBS (0.05M, pH 7.4) as supporting electrolyte. To perform
the first amperometric experiment, different concentrations of CBG in
the range of 5–90 μM were injected into the electrochemical cell where
potential was fixed at 0.09 V and its i-t curve can be seen in Fig. 9A. The
second amperometric experiment was the same as the first one but in
the presence of increasing concentration of HSA in the range of
1–40 μM and its i-t curve can be seen in in Fig. 9B. For building a ca-
libration curve for electrochemical sensing of HSA, Δi= i-i* values
were regressed on HSA concentrations which can be seen in Fig. 9C.
Two linear ranges of 1–9.5 μM and 9.5–40 μM were observed for the
biosensing of HSA. The sensitivity and limit of detection of the sensor
were calculated to be 6.47 μA μM−1 and 0.6 μM (according to 3SD/m,
where SD is the standard deviation of the intercept and m is the slope of
the calibration curve), respectively.
3.6.2. Interference study
Amperometric responses of the MWCNTs-IL/GCE to HSA (10 μM) in
the presence of 100-fold interfering species including (a) cysteine, (b)
tyrosine, (c) histidine, (d) valine, (e) methionine, (f) proline, (g) phe-
nylalanine, (h) egg albumin, (i) chloramphenicol, (j) amoxicillin, (k)
vitamin C and (l) vitamin B12 is shown in Fig. 9D. The results show that
the sensor had a selective response to HSA even in the presence of in-
terfering species.
3.6.3. Stability, repeatability, and reproducibility
Stability is an important characteristic for a sensor which must be
verified and reported. Therefore, the sensor was applied to weekly
determination of 10 μM HSA during six weeks. Results confirmed that
the sensor was able to retain 96.1% of its original response which was a
good guarantee for the stability of the sensor. The repeatability of the
sensor was also examined by the application of the sensor to determi-
nation of 10 μM HSA for ten times during a day and the results con-
firmed a good repeatability for the sensor whose relative standard de-
viation (RSD) was 2.41%. For verification of the reproducibility of the
sensor, six sensors were constructed and applied to the determination of
Fig. 9. (A) Amperometric responses recorded by MWCNTs-IL/GCE upon increasing concentration of CBG, (B) same as (A) but, in the presence of increasing con-
centration of HSA, (C) regression of Δi= i-i* on HAS concentrations and (D) amperometric responses of the sensor to HSA and in the presence of interfering species:
(a) cysteine, (b) tyrosine, (c) histidine, (d) valine, (e) methionine, (f) proline, (g) phenylalanine, (h) egg albumin, (i) chloramphenicol, (j) amoxicillin, (k) vitamin C
and (l) vitamin B12.
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10 μM HSA. A suitable value of 3.01% was found for RSD which con-
firmed reproducibility of the sensor response.
3.6.4. Validation of the developed methodology
For verification of the ability of the sensor for HSA determination in
human serum samples, its results were compared with the results of a
medical diagnostic laboratory which used capillary electrophoresis as
the reference method for the analysis of real samples. The results of the
two methods are collected in Table 2 and as can be seen, there is an
acceptable agreement between the two methods.
4. Conclusions
In the present study, interactions of CBG with HSA were in-
vestigated by experimental and computational methods which helped
us to have a deep inside to CBG-HSA interactions. Firstly, electro-
chemical and spectroscopic data were separately analysed to obtain
some information and then, by the combination of the data into an
augmented data matrix and analyzing by MCR-ALS new information
was extracted. The results of the multivariate analyses gave new in-
formation about the number of species involved and their stoichiometry
and their electrochemical nature. The CBG was also docked with HSA
by molecular docking methods which enabled us to obtain new in-
formation about the location of the CBG at HSA and type of its inter-
action with HSA. The results obtained from experimental and compu-
tational sections were compatible. Finally, a novel, fast, simple and low-
cost electroanalytical method was developed based on CBG-HSA in-
teractions for determination of electro-inactive HSA.
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